GKOS
the council passes — AVOIDGLAUKOS Corp·Healthcare
Doesn't clear the council's bar right now.
37/100D
Price at last run$151as of Jul 8, 2026
healthcareStrong gross margins56% gross margin.
GrowingRevenue growing ~32%.
Clean balance sheetLow leverage (debt/equity 0.00).
Catalystnone yet
✕Why not
The honest case against — what most tools hideWhat keeps us out
- A deterioration in the fundamentals that score the business.
Patience price & distance
as of Jul 8, 2026 runThe patience price is where value discipline would let the council in — deliberately strict: we'd rather miss ten winners than own one loser.
Catalyst
none yet
A catalyst is a plausible reason the gap could close — never a certainty.